Type in a keyword and see the report right away. Explore your online world!
If you have already a Newsmeter account:
You can free sign up for Newsmeter:
x
Merck will leverage SCRI’s Accelero™ delivery model to streamline trial operations with the goal of...
BALTIMORE , Aug. 14, 2026 /PRNewswire/ -- Nanochon, a medical device company developing Chondrograft™, a...
WINNIPEG, MB / ACCESS Newswire / August 14, 2026 / Medicure Inc. (' Medicure '...
Combined company to trade on Nasdaq and operate as Fibrx Therapeutics, a fibrosis-focused company led...
Otsuka Pharmaceuticals’ Voyxact is not the only IgA nephropathy drug that can slow the decline...
Sponsors of the pivotal study behind Amgen’s rare disease drug Tavneos saw unblinded findings for...
– Perceptive Advisors provides approximately $7.0 million of additional investment to further support strategic growth...
Capricor Therapeutics’ CEO Linda Marbán believes the FDA is willing to work with the biotech...
PTC Therapeutics emerged as the winning bidder over Astellas for Sangamo Therapeutics’ Fabry disease gene...
AstraZeneca will push through with its other Phase 3 studies for volrustomig, including in cervical...
Taiho Pharmaceutical and Cullinan Therapeutics’ cancer asset is already under FDA review in a later...
EyePoint’s quest to reduce treatment burden for patients with age-related macular degeneration has hit a...
Johnson & Johnson secured rights to prizlon-cel in 2023 for $245 million upfront. The asset...
Despite ranking among the world’s top scientific producers, Italy has struggled to turn research into...
Ivonescimab notched its third approval in China last week, but the label update has tempered...
